Severity by National Institute of Health Stroke Scale Score and Clinical Features of Stroke Patients with Patent Foramen Ovale Stroke and Atrial Fibrillation
-
- Kaito Abe
- Department of Cardiology, Omori Red Cross Hospital, 4-30-1 Chuo, Ota-Ward, Tokyo 143-8527, Japan
-
- Fumiya Hasegawa
- Department of Cardiology, Omori Red Cross Hospital, 4-30-1 Chuo, Ota-Ward, Tokyo 143-8527, Japan
-
- Ryota Nakajima
- Department of Cardiology, Omori Red Cross Hospital, 4-30-1 Chuo, Ota-Ward, Tokyo 143-8527, Japan
-
- Hidetoshi Fukui
- Department of Cardiology, Omori Red Cross Hospital, 4-30-1 Chuo, Ota-Ward, Tokyo 143-8527, Japan
-
- Moto Shimada
- Department of Cardiology, Omori Red Cross Hospital, 4-30-1 Chuo, Ota-Ward, Tokyo 143-8527, Japan
-
- Takahiro Miyazaki
- Department of Cardiology, Omori Red Cross Hospital, 4-30-1 Chuo, Ota-Ward, Tokyo 143-8527, Japan
-
- Hiroshi Doi
- Department of Cardiology, Omori Red Cross Hospital, 4-30-1 Chuo, Ota-Ward, Tokyo 143-8527, Japan
-
- Goro Endo
- Department of Cardiology, Omori Red Cross Hospital, 4-30-1 Chuo, Ota-Ward, Tokyo 143-8527, Japan
-
- Kaori Kanbara
- Department of Cardiology, Omori Red Cross Hospital, 4-30-1 Chuo, Ota-Ward, Tokyo 143-8527, Japan
-
- Yasuyuki Mochida
- Department of Cardiology, Omori Red Cross Hospital, 4-30-1 Chuo, Ota-Ward, Tokyo 143-8527, Japan
-
- Jun Okuda
- Department of Cardiology, Omori Red Cross Hospital, 4-30-1 Chuo, Ota-Ward, Tokyo 143-8527, Japan
-
- Nobuya Maeda
- Department of Neurology, Omori Red Cross Hospital, 4-30-1 Chuo, Ota-Ward, Tokyo 143-8527, Japan
-
- Akira Isoshima
- Department of Neurosurgery, Omori Red Cross Hospital, 4-30-1 Chuo, Ota-Ward, Tokyo 143-8527, Japan
-
- Koichi Tamura
- Department of Medical Science and Cardiorenal Medicine, Yokohama City University, 3-9 Fukuura Kanazawa-Ward, Yokohama City 236-0004, Japan
-
- Tomoaki Ishigami
- Department of Medical Science and Cardiorenal Medicine, Yokohama City University, 3-9 Fukuura Kanazawa-Ward, Yokohama City 236-0004, Japan
説明
<jats:p>The comparative severity of patent foramen ovale (PFO)-related stroke in patients without atrial fibrillation (AF) and AF-related stroke in patients without PFO is unknown. Therefore, we compared the severity of PFO-related stroke and AF-related stroke. Twenty-six patients who underwent transesophageal echocardiography (TEE) were diagnosed with cardioembolic stroke from July 2018 to March 2020. Cases with AF detected by electrocardiograms or thrombus in the left atrium or left atrial appendage on TEE were included in the AF-related stroke group. Cases with a positive microbubble test on the Valsalva maneuver during TEE, and with no other factors that could cause stroke, were included in the PFO-related stroke group. This study was designed as a single-center, small population pilot study. The stroke severity of the two groups by the National Institute of Health Stroke Scale (NIHSS) score was compared by statistical analysis. Of the 26 cases, five PFO-related stroke patients and 21 AF-related stroke patients were analyzed. The NIHSS score was 2.2 ± 2.8 and 11.5 ± 9.2 (p-value < 0.01), the rate of hypertension was 20.0% and 85.7% (p-value = 0.01), and the HbA1c value was 5.5 ± 0.2% and 6.3 ± 1.3% (p-value = 0.02) in the PFO-related and AF-related stroke groups, respectively. Compared with AF-related stroke patients, stroke severity was low in PFO-related stroke patients.</jats:p>
収録刊行物
-
- Journal of Clinical Medicine
-
Journal of Clinical Medicine 10 (2), 332-, 2021-01-18
MDPI AG